Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Magle Chemoswed Holding

29.2

 

SEK

 

-0.68 %

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
-0.68%
-6.41%
-16.09%
-16.09%
-28.15%
-8.96%
+3.95%
-
+45.32%

The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Read more
Market cap
599.07M SEK
Turnover
1.26K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
26.5.
2025

General meeting '25

All
Press releases
3rd party
ShowingAll content types
Press release3/28/2025, 1:35 PM

Magle Chemoswed Holding AB (publ): Magle Group to BioStock: We live by the mantra `earn it before you burn it'

Magle Chemoswed Holding
Press release3/27/2025, 12:28 PM

Redeye: Magle Chemoswed Q4 - Delivering on its growth trajectory

Magle Chemoswed Holding
Regulatory press release3/27/2025, 7:30 AM

Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024

Magle Chemoswed Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release3/24/2025, 11:35 AM

Magle Chemoswed Holding AB (publ): BioStock: Magle Group launches multicenter trial with pancreatic leakage indicator

Magle Chemoswed Holding
Press release3/19/2025, 7:15 AM

Magle Group initiates Randomized Controlled Multicenter Trial with leading European university hospitals to explore SmartPAN® efficacy

Magle Chemoswed Holding
Regulatory press release2/26/2025, 5:00 PM

Ingela Fritzson resigns from the Board of Directors of Magle Group

Magle Chemoswed Holding
Press release2/17/2025, 8:00 AM

Magle Group is pleased to announce Magle PharmaCept’s participation in the DPC, German Pancreatic Club congress, set to take place February 27-March 1, 2025, in Heidelberg, Germany.

Magle Chemoswed Holding
Regulatory press release2/14/2025, 7:05 AM

Magle Group Announces Revised Publication Date for Q4 2024 and Full-Year 2024 Reports Due to Ongoing Consolidation Process

Magle Chemoswed Holding
Regulatory press release1/9/2025, 8:45 PM

Magle Group announces allocation in the directed share issue

Magle Chemoswed Holding
Regulatory press release12/30/2024, 11:30 AM

Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB

Magle Chemoswed Holding
Regulatory press release12/20/2024, 2:30 PM

Magle Group raises approximately SEK 36.8 million in the rights issue

Magle Chemoswed Holding
Regulatory press release12/16/2024, 2:30 PM

Magle Group publishes supplementary prospectus

Magle Chemoswed Holding
Press release12/16/2024, 9:40 AM

Magle Group Approves Multi-Centre Clinical Trial in Genicular Artery Embolisation for Osteoarthritis Pain Relief

Magle Chemoswed Holding
Regulatory press release12/12/2024, 9:45 PM

Notice to the extraordinary general meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed Holding
Regulatory press release12/12/2024, 9:00 PM

Magle Group resolves on a conditional directed share issue of up to approximately SEK 26.6 million

Magle Chemoswed Holding
Regulatory press release12/10/2024, 5:00 PM

Magle Group publishes supplementary prospectus

Magle Chemoswed Holding
Regulatory press release12/5/2024, 7:50 AM

Announcement of CFO Petra Jönsson Sjölin’s Resignation

Magle Chemoswed Holding
Regulatory press release12/5/2024, 7:50 AM

Appointment of Aaron Wong as CFO of Magle Group

Magle Chemoswed Holding
Press release12/4/2024, 12:00 PM

Correction: Nomination Committee appointed for the annual general meeting 2025 in Magle Chemoswed Holding

Magle Chemoswed Holding
Regulatory press release12/3/2024, 10:30 AM

Nomination Committee appointed for the Annual General Meeting 2025 in Magle Chemoswed Holding

Magle Chemoswed Holding
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.